Display options
Cite
Subramanian S, Costales A, Williams TE, et al. Correction to Design and Synthesis of Orally Bioavailable Benzimidazole Reverse Amides as Pan RAF Kinase Inhibitors. ACS Med Chem Lett. 2014;5(12):1340doi: 10.1021/ml500461g.
Subramanian, S., Costales, A., Williams, T. E., Levine, B., McBride, C. M., Poon, D., Amiri, P., Renhowe, P. A., Shafer, C. M., Stuart, D., Verhagen, J., & Ramurthy, S. (2014). Correction to Design and Synthesis of Orally Bioavailable Benzimidazole Reverse Amides as Pan RAF Kinase Inhibitors. ACS medicinal chemistry letters, 5(12), 1340. https://doi.org/10.1021/ml500461g
Subramanian, Sharadha, et al. "Correction to Design and Synthesis of Orally Bioavailable Benzimidazole Reverse Amides as Pan RAF Kinase Inhibitors." ACS medicinal chemistry letters vol. 5,12 (2014): 1340. doi: https://doi.org/10.1021/ml500461g
Subramanian S, Costales A, Williams TE, Levine B, McBride CM, Poon D, Amiri P, Renhowe PA, Shafer CM, Stuart D, Verhagen J, Ramurthy S. Correction to Design and Synthesis of Orally Bioavailable Benzimidazole Reverse Amides as Pan RAF Kinase Inhibitors. ACS Med Chem Lett. 2014 Nov 25;5(12):1340. doi: 10.1021/ml500461g. eCollection 2014 Dec 11. PMID: 25514817; PMCID: PMC4265813.
Copy Download .nbib Format: NLM
Share it on

ACS Med Chem Lett. 2014 Nov 25;5(12):1340. doi: 10.1021/ml500461g. eCollection 2014 Dec 11.

Correction to Design and Synthesis of Orally Bioavailable Benzimidazole Reverse Amides as Pan RAF Kinase Inhibitors.

ACS medicinal chemistry letters

Sharadha Subramanian, Abran Costales, Teresa E Williams, Barry Levine, Christopher M McBride, Daniel Poon, Payman Amiri, Paul A Renhowe, Cynthia M Shafer, Darrin Stuart, Joelle Verhagen, Savithri Ramurthy

PMID: 25514817 PMCID: PMC4265813 DOI: 10.1021/ml500461g

Abstract

[This corrects the article DOI: 10.1021/ml5002272.].

Publication Types